Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online October 12, 2006
Stem Cells Vol. 25 No. 2 February 2007, pp. 411 -418
doi:10.1634/stemcells.2006-0380; www.StemCells.com
© 2007 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
2006-0380v1
25/2/411    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sonntag, K.-C.
Right arrow Articles by Isacson, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sonntag, K.-C.
Right arrow Articles by Isacson, O.

EMBRYONIC STEM CELLS

Enhanced Yield of Neuroepithelial Precursors and Midbrain-Like Dopaminergic Neurons from Human Embryonic Stem Cells Using the Bone Morphogenic Protein Antagonist Noggin

Kai-Christian Sonntag, Jan Pruszak, Takahito Yoshizaki, Joris van Arensbergen, Rosario Sanchez-Pernaute, Ole Isacson

Center for Neuroregeneration Research, Udall Parkinson's Disease Center of Excellence, McLean Hospital, Harvard Medical School, Belmont, Massachusetts, USA

Key Words. Human embryonic stem cells • Dopamine • Differentiation • Noggin • Parkinson's disease6-Hydroxydopamine-lesioned rats

Correspondence: Kai-Christian Sonntag, M.D., Ph.D., Harvard Medical School, Center for Neuroregeneration Research, MRC 126, McLean Hospital, 115 Mill Street, Belmont, Massachusetts 02478, USA. Telephone: 617-855-3138; Fax: 617-855-3284; e-mail: kai.sonntag{at}mclean.harvard.edu

Received June 22, 2006; accepted for publication October 5, 2006.
First published online in STEM CELLS EXPRESS   October 12, 2006.



It is currently not known whether dopamine (DA) neurons derived from human embryonic stem cells (hESCs) can survive in vivo and alleviate symptoms in models of Parkinson disease (PD). Here, we report the use of Noggin (a bone morphogenic protein antagonist) to induce neuroectodermal cell development and increase the yield of DA neurons from hESCs. A combination of stromal-derived inducing activity and Noggin markedly enhanced the generation of neuroepithelial progenitors that could give rise to DA neurons. In addition, Noggin diminished the occurrence of a fibroblast-like Nestin-positive precursor population that differentiated into myocytes. After transplantation of differentiated hESCs to a rodent model of PD, some grafts contained human midbrain-like DA neurons. This protocol demonstrates hESC derivation and survival of human DA neurons appropriate for cell therapy in PD.




This article has been cited by other articles:


Home page
Mol Hum ReprodHome page
T. Song, G. Chen, Y. Wang, G. Mao, Y. Wang, and H. Bai
Chemically defined sequential culture media for TH+ cell derivation from human embryonic stem cells
Mol. Hum. Reprod., November 1, 2008; 14(11): 619 - 625.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
S. Chiba, Y. M. Lee, W. Zhou, and C. R. Freed
Noggin Enhances Dopamine Neuron Production from Human Embryonic Stem Cells and Improves Behavioral Outcome After Transplantation into Parkinsonian Rats
Stem Cells, November 1, 2008; 26(11): 2810 - 2820.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Aubry, A. Bugi, N. Lefort, F. Rousseau, M. Peschanski, and A. L. Perrier
Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats
PNAS, October 28, 2008; 105(43): 16707 - 16712.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
A. de Chevigny, O. Cooper, A. Vinuela, C. Reske-Nielsen, D. C. Lagace, A. J. Eisch, and O. Isacson
Fate Mapping and Lineage Analyses Demonstrate the Production of a Large Number of Striatal Neuroblasts After Transforming Growth Factor {alpha} and Noggin Striatal Infusions into the Dopamine-Depleted Striatum
Stem Cells, September 1, 2008; 26(9): 2349 - 2360.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
R. Sanchez-Pernaute, H. Lee, M. Patterson, C. Reske-Nielsen, T. Yoshizaki, K. C. Sonntag, L. Studer, and O. Isacson
Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease
Brain, August 1, 2008; 131(8): 2127 - 2139.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
G. W. Yeo, N. Coufal, S. Aigner, B. Winner, J. A. Scolnick, M. C.N. Marchetto, A. R. Muotri, C. Carson, and F. H. Gage
Multiple layers of molecular controls modulate self-renewal and neuronal lineage specification of embryonic stem cells
Hum. Mol. Genet., April 15, 2008; 17(R1): R67 - R75.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. Gaulden and J. F. Reiter
Neur-ons and neur-offs: regulators of neural induction in vertebrate embryos and embryonic stem cells
Hum. Mol. Genet., April 15, 2008; 17(R1): R60 - R66.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
A. K. Yocum, T. E. Gratsch, N. Leff, J. R. Strahler, C. L. Hunter, A. K. Walker, G. Michailidis, G. S. Omenn, K. S. O'Shea, and P. C. Andrews
Coupled Global and Targeted Proteomics of Human Embryonic Stem Cells during Induced Differentiation
Mol. Cell. Proteomics, April 1, 2008; 7(4): 750 - 767.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
X.-J. Li, B.-Y. Hu, S. A. Jones, Y.-S. Zhang, T. LaVaute, Z.-W. Du, and S.-C. Zhang
Directed Differentiation of Ventral Spinal Progenitors and Motor Neurons from Human Embryonic Stem Cells by Small Molecules
Stem Cells, April 1, 2008; 26(4): 886 - 893.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. S. Cho, Y.-E. Lee, J. Y. Kim, S. Chung, Y. H. Cho, D.-S. Kim, S.-M. Kang, H. Lee, M.-H. Kim, J.-H. Kim, et al.
Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells
PNAS, March 4, 2008; 105(9): 3392 - 3397.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
D. Yang, Z.-J. Zhang, M. Oldenburg, M. Ayala, and S.-C. Zhang
Human Embryonic Stem Cell-Derived Dopaminergic Neurons Reverse Functional Deficit in Parkinsonian Rats
Stem Cells, January 1, 2008; 26(1): 55 - 63.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
J. Pruszak, K.-C. Sonntag, M. H. Aung, R. Sanchez-Pernaute, and O. Isacson
Markers and Methods for Cell Sorting of Human Embryonic Stem Cell-Derived Neural Cell Populations
Stem Cells, September 1, 2007; 25(9): 2257 - 2268.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
E. Hedlund, J. Pruszak, A. Ferree, A. Vinuela, S. Hong, O. Isacson, and K.-S. Kim
Selection of Embryonic Stem Cell-Derived Enhanced Green Fluorescent Protein-Positive Dopamine Neurons Using the Tyrosine Hydroxylase Promoter Is Confounded by Reporter Gene Expression in Immature Cell Populations
Stem Cells, May 1, 2007; 25(5): 1126 - 1135.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2007 by AlphaMed Press.